Case number 2020-2159
Sanofi-Aventis Deutschland v. Hirshfeld > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 22, 2022 | 19 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [832654] [20-1871, 20-2029, 20-2032, 20-2033, 20-2034, 20-2159] [MVH] [Entered: 02/22/2022 02:07 PM] (3) |
| Dec 29, 2021 | 17 | OPINION filed for the court by Dyk, Circuit Judge; Clevenger, Circuit Judge and Taranto, Circuit Judge. Nonprecedential Per Curiam Opinion. Service as of this date by the Clerk of Court. [821652] [20-1871, 20-2029, 20-2032, 20-2033, 20-2034, 20-2159] [MVH] [Entered: 12/29/2021 09:49 AM] (6) |
| Dec 29, 2021 | 18 | JUDGMENT. AFFIRMED IN PART, DISMISSED IN PART. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [821654] [20-1871, 20-2029, 20-2032, 20-2033, 20-2034, 20-2159] [MVH] [Entered: 12/29/2021 09:50 AM] (3) |
| Jun 23, 2021 | 16 | ORDER filed. Within 14 days from the date of this order, the parties that raised an Appointments Clause challenge shall file a brief, not to exceed 10 pages double-spaced, explaining how they believe their cases should proceed in light of Arthrex. Responses from the other parties, including the United States Patent and Trademark Office, subject to the same length restrictions, are due within 14 days thereafter. All deadlines and proceedings are stayed. Service as of this date by the Clerk of Court. [782106] [20-1587, 20-1588, 20-1589, 20-1590, 20-1591, 20-1592, 20-1593, 20-1594, 20-1654, 20-1747, 20-1748, 20-1749, 20-1750, 20-1751, 20-1752, 20-1871, 20-2029, 20-2032, 20-2033, 20-2034, 20-2159] [MJL] [Entered: 06/23/2021 04:58 PM] (2) |
| Jan 27, 2021 | 15 | ORDER granting [748890-2] [748891-2] [748893-2] the motions. The revised official captions are reflected above. Appeal No. 2020-2144 is withdrawn. Each side shall bear its own costs with respect to Appeal No. 2020-2144. ISSUED AS A MANDATE (as to Appeal No. 2020-2144 only): January 27, 2021. Service as of this date by the Clerk of Court. [751964] [20-1871, 20-2029, 20-2032, 20-2033, 20-2034, 20-2159, 20-2066, 20-2068, 20-2069, 20-2071, 20-2144] [LMS] [Entered: 01/27/2021 08:28 AM] (0) |
| Jan 22, 2021 | 14 | Official caption revised to reflect Andrew Hirshfeld, Performing the Functions and Duties of the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, as Intervenor (see attached). Service as of this date by the Clerk of Court. [751251] [EKD] [Entered: 01/22/2021 04:32 PM] (0) |
| Jan 21, 2021 | 13 | ORDER granting motions [737383-2], [737385-2], [737387-2], & [737390-2] to the extent that the appeals shall be considered companion cases and assigned to the same merits panel. Sanofi’s motion to dismiss [727706-2] is denied. The parties are directed to address the standing issues in their briefs. Pfizer’s motion [731906-2] is granted to the extent provided herein. ECF Nos. 14 and 15 in Appeal Nos. 2020-2071, -2139, -2144 are accepted for filing. The Director of the United States Patent and Trademark Office is added as an intervenor. The revised official captions are reflected in the order. (See order for briefing details) Service as of this date by the Clerk of Court. [750712] [20-1871, 20-2029, 20-2159, 20-2066, 20-2071, 21-1262] [NL] [Entered: 01/21/2021 04:36 PM] (0) |
| Sep 29, 2020 | 12 | Certified list received. Service: 09/29/2020 by email. [725134] [LMN] [Entered: 09/29/2020 12:53 PM] (0) |
| Sep 25, 2020 | 10 | ORDER granting motions to consolidate appeals [716201-2], [712826-2],[5], filed by Appellant Sanofi-Aventis Deutschland GmbH. in 20-1871 and 20-2159; denying [712826-3], [712838-3] motions to waive requirements of brief or appendix filed by Sanofi-Aventis Deutschland GmbH in 20-1871 and 20-2033; denying [712826-4], [712838-4], motions to set briefing schedule filed by Sanofi-Aventis Deutschland GmbH in 20-1871 and 20-2033; deconsolidating appeals in 20-1871, 20-2033, and 20-2034. The stays of the briefing schedules are lifted. The opening briefs for each group of appeals are due within 60 days from the filing date of the last-filed Certified List within each group. Service as of this date by the Clerk of Court. [724420] [20-1871, 20-2029, 20-2032, 20-2033, 20-2034, 20-2159] [LMN] [Entered: 09/25/2020 10:06 AM] (0) |
| Sep 25, 2020 | 11 | Note to File: The following cases are consolidated: 20-1871 Lead with 20-2029, 20-2032, 20-2033, 20-2034, and 20-2159 Member Cases. The parties must file all documents in the lead appeal only. [724429] [20-1871, 20-2029, 20-2032, 20-2033, 20-2034, 20-2159] [LMN] [Entered: 09/25/2020 10:22 AM] (0) |
| Aug 25, 2020 | 9 | ORDER staying the briefing schedules pending disposition of the motions. Service as of this date by the Clerk of Court. [717299] [20-1871, 20-2033, 20-2068, 20-2159] [LMS] [Entered: 08/25/2020 11:05 AM] (0) |
| Aug 24, 2020 | 6 | Entry of appearance for Charles B. Klein; Jovial Wong; Dan H. Hoang as counsel for Appellee Pfizer Inc.. Service: 08/24/2020 by email. [717157] [20-2159] [Charles Klein] [Entered: 08/24/2020 05:26 PM] (0) |
| Aug 24, 2020 | 7 | Certificate of Interest for Appellee Pfizer Inc.. Service: 08/24/2020 by email. [717158] [20-2159] [Charles Klein] [Entered: 08/24/2020 05:29 PM] (0) |
| Aug 24, 2020 | 8 | Docketing Statement for the Appellee Pfizer Inc.. Service: 08/24/2020 by email. [717160] [20-2159] [Charles Klein] [Entered: 08/24/2020 05:30 PM] (0) |
| Aug 20, 2020 | 5 | MOTION of Appellant Sanofi-Aventis Deutschland GmbH to consolidate appeals (2020-2159 and 2020-1871) [Consent: unopposed]. Service: 08/20/2020 by email. [716203] [20-2159] [Adam Banks] [Entered: 08/20/2020 02:11 PM] (8) |
| Aug 19, 2020 | 2 | Entry of appearance for Adam B. Banks; Elizabeth Stotland Weiswasser; Anish R. Desai; William Sutton Ansley; Sarah M. Sternlieb as counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 08/19/2020 by email. [715811] [20-2159] [Adam Banks] [Entered: 08/19/2020 10:24 AM] (2) |
| Aug 19, 2020 | 3 | Certificate of Interest for Appellant Sanofi-Aventis Deutschland GmbH. Service: 08/19/2020 by email. [715812] [20-2159] [Adam Banks] [Entered: 08/19/2020 10:26 AM] (3) |
| Aug 19, 2020 | 4 | Docketing Statement for the Appellant Sanofi-Aventis Deutschland GmbH. Service: 08/19/2020 by email. [715813] [20-2159] [Adam Banks] [Entered: 08/19/2020 10:29 AM] (3) |
| Aug 17, 2020 | 1 | Appeal docketed. Received: 08/14/2020. [715239] Entry of Appearance is due on 08/31/2020. Certificate of Interest is due on 08/31/2020. Docketing Statement is due on 08/31/2020. Certified List is due on 09/28/2020. [KMH] [Entered: 08/17/2020 01:40 PM] (118) |
